Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Migrants from certain regions had a higher risk of COVID-19 than Spaniards.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

Bald men may have higher heart disease risk.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Premature hair greying may indicate a higher risk of metabolic problems.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Baldness may indicate higher heart disease risk in men.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

People with alopecia areata have a higher risk of stroke.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Physical activity, height, and smoking affect prostate cancer risk.

Age, stress, and anger increase the risk of hair fall.

Water near Abakaliki mines has high toxic metal levels, posing health risks.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Many survivors of critical illness, especially those with sepsis, experience hair loss.

Spironolactone might lower the chance of getting rosacea.

WomenCare helps predict PCOD risk in women to encourage early medical consultation.

GLP-1RA therapy may increase the risk of hair loss.

Cosmetics can contain harmful chemicals that may cause health issues.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

Obesity is an independent risk factor for early coronary artery disease (CAD) and its severity is not affected by age.